Idiopathic Dyspepsia
- PMID: 15769439
- DOI: 10.1007/s11938-005-0010-3
Idiopathic Dyspepsia
Abstract
Idiopathic dyspepsia refers to pain and/or discomfort perceived in the epigastrium that is not secondary to organic, systemic, or metabolic diseases. Symptoms may overlap with those of gastroesophageal reflux disease and irritable bowel syndrome. Gastrointestinal motor disorders, hypersensitivity to mechanical or chemical stimuli, and psychosocial factors can act individually or in concert to induce the symptoms of dyspepsia. Accordingly, there is no single therapy, and treatment must be individualized. Eradication of Helicobacter pylori infection rarely achieves symptom improvement. Treatment of idiopathic dyspepsia should begin by reassuring the patient about the benign nature of the syndrome and educating them on the knowledge that has been achieved in recent years regarding potential causes of the syndrome. Both prokinetic and antisecretory drugs have been reported to improve dyspeptic symptoms, but results are not completely convincing. Although well-designed studies demonstrate superiority of proton pump inhibitors over placebo, it should be noted that patients with nonerosive gastroesophageal reflux disease were invariably included; when these patients are excluded, the benefit of antisecretory medications is questionable. We suggest that patients with idiopathic dyspepsia be initially treated according to the predominant symptom. Those with epigastric pain/burning should receive a trial with standard doses of proton pump inhibitors for 4 to 8 weeks, whereas prokinetic patients should be prescribed at recommended doses for similar periods of time to patients with nonpainful dyspeptic symptoms such as posprandial fullness, early satiety, nausea, or vomiting. Nonresponders may benefit from combination therapies or short trials with higher doses of drugs. Visceral analgesics and antidepressants can also be prescribed alone or in combinations with other therapeutic strategies. Recent studies demonstrate utility for psychologic therapy and hypnotherapy, although truly controlled studies are difficult in this area. Herbal medicines deserve further evaluation.
Similar articles
-
Functional (Nonulcer) Dyspepsia.Curr Treat Options Gastroenterol. 2002 Apr;5(2):153-160. doi: 10.1007/s11938-002-0063-5. Curr Treat Options Gastroenterol. 2002. PMID: 11879596
-
Functional dyspepsia: a pragmatic approach.Rom J Intern Med. 2010;48(1):9-15. Rom J Intern Med. 2010. PMID: 21180236 Review.
-
Current management strategies and emerging treatments for functional dyspepsia.Nat Rev Gastroenterol Hepatol. 2013 Mar;10(3):187-94. doi: 10.1038/nrgastro.2013.11. Epub 2013 Feb 5. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23381190 Review.
-
Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying.Am J Gastroenterol. 1998 Nov;93(11):2082-8. doi: 10.1111/j.1572-0241.1998.00597.x. Am J Gastroenterol. 1998. PMID: 9820377
-
Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction.J Neurogastroenterol Motil. 2011 Jul;17(3):235-44. doi: 10.5056/jnm.2011.17.3.235. Epub 2011 Jul 13. J Neurogastroenterol Motil. 2011. PMID: 21860815 Free PMC article.
References
LinkOut - more resources
Full Text Sources